A selective MAGL inhibitor called KML29 reduced inflammatory and nerve pain in mice without causing the typical cannabis-like side effects of sedation, temperature drop, and immobility.
Read this if you are interested in how the endocannabinoid system could be targeted for pain relief without the side effects of THC.
Pain relief achieved without sedation, hypothermia, or immobility
What the researchers found
Researchers tested KML29, a highly selective inhibitor of the enzyme MAGL (which breaks down the endocannabinoid 2-AG), in mouse models of pain. KML29 completely reversed inflammatory pain and partially reversed nerve injury pain. It also completely prevented stomach bleeding caused by the anti-inflammatory drug diclofenac.
Critically, KML29 did not produce the classic cannabis-like side effects (catalepsy, hypothermia, reduced movement) that limit the use of THC and full cannabinoid receptor agonists. However, repeated high-dose treatment led to tolerance, accompanied by CB1 receptor desensitization.
The compound increased brain 2-AG levels while reducing arachidonic acid levels, without affecting anandamide levels, confirming its selective action on the 2-AG pathway.
Why it matters
Pain management is one of the most promising applications of the endocannabinoid system. Showing that 2-AG elevation via MAGL inhibition can produce pain relief without the psychoactive side effects of THC represents a potential path toward cannabinoid-based painkillers that do not impair daily function.
The numbers in context
KML29 completely reversed carrageenan-induced mechanical allodynia. Partially reversed sciatic nerve injury allodynia. Completely prevented diclofenac gastric hemorrhages. No catalepsy, hypothermia, or hypomotility observed.
How the study worked
In vivo testing in mice using carrageenan-induced inflammatory pain, sciatic nerve injury neuropathic pain, and diclofenac-induced gastric hemorrhage models. Cannabis-like side effects were assessed through locomotor activity, body temperature, catalepsy, and drug discrimination tests.
What this study cannot tell us
Mouse studies do not directly predict human outcomes. Tolerance developed with repeated high-dose administration, which could limit long-term clinical use. Only acute and short-term dosing protocols were tested.
How to read the evidence
Well-designed preclinical study with multiple pain models and side effect assessments, but limited to mice.
When this study was published
Published in 2014. MAGL inhibitors continue to be developed for pain.
The bigger picture
The endocannabinoid system offers multiple drug targets. Rather than activating cannabinoid receptors directly (like THC), boosting the body's own endocannabinoid 2-AG by blocking its breakdown may provide therapeutic benefits with fewer side effects. This "indirect" approach is a major focus of cannabinoid drug development.
Questions still open
- Would MAGL inhibitors work for chronic pain in humans? Can the tolerance issue be managed with dosing strategies? Would combining MAGL inhibitors with other approaches provide synergistic pain relief?
Common questions
Can you get pain relief from the endocannabinoid system without getting high?
What is MAGL?
Read the original research
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.
British journal of pharmacology, 171(6), 1392-407
Citation
Ignatowska-Jankowska, B M; Ghosh, S; Crowe, M S; Kinsey, S G; Niphakis, M J; Abdullah, R A; Tao, Q; O' Neal, S T; Walentiny, D M; Wiley, J L; Cravatt, B F; Lichtman, A H. (2014). In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.. British journal of pharmacology, 171(6), 1392-407. https://doi.org/10.1111/bph.12298
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk